>More throughput is not a good thing if the hospital is losing money on each patient.<
I have no idea why you're assuming they'd lose money on a Toc-paclitaxel patient.
My point is that the differential in cost to the system between 15 minutes of bed time and 3 hours of bed time gives Sonus plenty of room to command a premium. Increased throughput has successfully been used as a rationale for vastly more expensive branded antithrombotics, and the difference is trivial compared with 15 min vs 3 h.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.